The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
A first-in-human study of CD123 NK cell engager SAR443579 in relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or high-risk myelodysplasia.
 
Anthony Selwyn Stein
Speakers' Bureau - Amgen
 
Mojca Jongen-Lavrencic
No Relationships to Disclose
 
Sylvain Garciaz
No Relationships to Disclose
 
Gerwin A Huls
No Relationships to Disclose
 
Abhishek Maiti
Research Funding - Celgene (Inst); Lin BioScience (Inst)
 
Nicolas Boissel
Honoraria - Amgen; ARIAD/Incyte; Astellas Pharma; Novartis; SERVIER
Consulting or Advisory Role - Amgen; Novartis; SERVIER
Research Funding - Amgen; Novartis
Expert Testimony - Amgen
 
Stéphane De Botton
Honoraria - Abbvie; Astellas Pharma; Celgene; Daiichi Sankyo Pharmaceutical; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Agios; Forma Therapeutics
 
Shaun Fleming
Honoraria - Amgen; Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Novartis; Pfizer
Speakers' Bureau - Amgen; Pfizer
Research Funding - Amgen
 
C Michel Zwaan
Consulting or Advisory Role - Abbvie (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Kura Oncology (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Research Funding - Abbvie/Genentech (Inst); Daiichi Sankyo (Inst); Jazz Pharmaceuticals (Inst); Kura Oncology (Inst); Pfizer (Inst); Takeda (Inst)
 
David C. de Leeuw
Consulting or Advisory Role - Abbvie; Roche; SERVIER; Takeda
Travel, Accommodations, Expenses - Abbvie
 
Pinkal Desai
Employment - Janssen
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; SERVIER
Research Funding - Janssen Research & Development
 
Martha Lucia Arellano
No Relationships to Disclose
 
David Avigan
Employment - Parexel
Consulting or Advisory Role - Aviv MedTech; Bristol-Myers Squibb; Celgene; Chugai Pharma; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite/Gilead; Kowa Pharmaceutical; Legend Biotech; Partner Therapeutics; Sanofi; Takeda; Takeda
Research Funding - Celgene; Kite, a Gilead company; Pharmacyclics
 
Saskia Langemeijer
No Relationships to Disclose
 
Kyle A. Jensen
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Timothy Wagenaar
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Gu Mi
No Relationships to Disclose
 
Giovanni Abbadessa
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Ashish Bajel
Honoraria - Abbvie; Amgen; Astellas Pharma; Novartis; Pfizer
Speakers' Bureau - Amgen